Announcements Trials
Browse Landscape

Phase

Phase NA 23Phase 2/3 6Phase 1/2 6Phase 2 4Phase 1 3Phase EARLY_PHASE1 1Phase 3 1

Status

Unknown 4Completed 4Terminated 3Recruiting 2

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1Dermatologic 1

Conditions

Squamous Intraepithelial Lesions 1Skin Neoplasms 1Melanoma 1HIV Seropositivity 1Colorectal Liver Metastases 1Carcinoma, Hepatocellular 1

Interventions

Cyclophosphamide 741Cisplatin 688Gemcitabine 641Bevacizumab 616Carboplatin 605Paclitaxel 601Docetaxel 565Radiotherapy 536Fluorouracil 405Oxaliplatin 387Rituximab 369Doxorubicin 361Capecitabine 342Filgrastim 333Etoposide 330Dexamethasone 312Irinotecan 309pembrolizumab 282Leucovorin 274Cetuximab 268Cytarabine 242Erlotinib Hydrochloride 231Nivolumab 228Prednisone 227Trastuzumab 225Vincristine 221Bortezomib 221Methotrexate 207Pemetrexed 199fludarabine phosphate 195

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Completed × Electroporation × Clear all
NCT03603808 2026-05-08

VGX-3100 and Electroporation in Treating Patients With HIV-Positive High-Grade Anal Lesions

AIDS Malignancy Consortium

Phase 2 Completed
44 enrolled 15 charts
Gynecologic

Squamous Intraepithelial Lesions, HIV Seropositivity

NCT04526730 2026-02-20

Neoadjuvant Immunotherapy With Tavo + Electroporation in Combination With Nivo. in Melanoma Patients

H. Lee Moffitt Cancer Center and Research Institute

Phase 2 Completed
17 enrolled 11 charts
Dermatologic

Melanoma, Skin Neoplasms

NCT03630640 2024-07-31

NIVOLEP

Assistance Publique - Hôpitaux de Paris

Phase 2 Completed
43 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02082782 2022-12-20

COLDFIRE-2

Amsterdam UMC, location VUmc

Phase 2 Completed
51 enrolled
Gastrointestinal

Colorectal Liver Metastases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡